BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oram RA, Sims EK, Evans-Molina C. Beta cells in type 1 diabetes: mass and function; sleeping or dead? Diabetologia 2019;62:567-77. [PMID: 30767048 DOI: 10.1007/s00125-019-4822-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Ikegami H, Babaya N, Noso S. β-Cell failure in diabetes: Common susceptibility and mechanisms shared between type 1 and type 2 diabetes. J Diabetes Investig 2021;12:1526-39. [PMID: 33993642 DOI: 10.1111/jdi.13576] [Reference Citation Analysis]
2 Jaakkola MK, Elo LL. Estimating cell type-specific differential expression using deconvolution. Brief Bioinform 2021:bbab433. [PMID: 34651640 DOI: 10.1093/bib/bbab433] [Reference Citation Analysis]
3 Powers AC. Type 1 diabetes mellitus: much progress, many opportunities. J Clin Invest 2021;131:142242. [PMID: 33759815 DOI: 10.1172/JCI142242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Thomas R, Carballido JM, Wesley JD, Ahmed ST. Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes. Front Immunol 2021;12:730414. [PMID: 34421931 DOI: 10.3389/fimmu.2021.730414] [Reference Citation Analysis]
5 Bolla AM, Usuelli V, Ben Nasr M, Frigerio S, Loretelli C, D'Addio F, Fiorina P. Next-gen therapeutics to spare and expand beta-cell mass. Curr Opin Pharmacol 2021;61:77-82. [PMID: 34649215 DOI: 10.1016/j.coph.2021.09.001] [Reference Citation Analysis]
6 Tang S, Zhang M, Zeng S, Huang Y, Qin M, Nasri U, Santamaria P, Riggs AD, Jin L, Zeng D. Reversal of autoimmunity by mixed chimerism enables reactivation of β cells and transdifferentiation of α cells in diabetic NOD mice. Proc Natl Acad Sci U S A 2020;117:31219-30. [PMID: 33229527 DOI: 10.1073/pnas.2012389117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Wang Y, Qin Y, Gu H, Zhang L, Wang J, Huang Y, Shi Y, Hu Q, Chen Y, Gu Y, Shi Y, Tao Y, Zhang M. High Residual β-cell Function in Chinese Patients With Autoimmune Type 1 Diabetes. J Clin Endocrinol Metab 2022;107:e2348-58. [PMID: 35218654 DOI: 10.1210/clinem/dgac077] [Reference Citation Analysis]
8 Miller RG, Yu L, Becker DJ, Orchard TJ, Costacou T. Older age of childhood type 1 diabetes onset is associated with islet autoantibody positivity >30 years later: the Pittsburgh Epidemiology of Diabetes Complications Study. Diabet Med 2020;37:1386-94. [PMID: 32011014 DOI: 10.1111/dme.14261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Gan Q, Lin C, Lu C, Chang Y, Che Q, Zhang G, Zhu T, Gu Q, Wu Z, Li M, Li D. Staprexanthones, Xanthone-Type Stimulators of Pancreatic β-Cell Proliferation from a Mangrove Endophytic Fungus. J Nat Prod 2020;83:2996-3003. [PMID: 32966070 DOI: 10.1021/acs.jnatprod.0c00535] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wu SY, Liang J, Yang BC, Leung PS. SIRT1 Activation Promotes β-Cell Regeneration by Activating Endocrine Progenitor Cells via AMPK Signaling-Mediated Fatty Acid Oxidation. Stem Cells 2019;37:1416-28. [PMID: 31400234 DOI: 10.1002/stem.3073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
11 Nakayasu ES, Qian WJ, Evans-Molina C, Mirmira RG, Eizirik DL, Metz TO. The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes. Expert Rev Proteomics 2019;16:569-82. [PMID: 31232620 DOI: 10.1080/14789450.2019.1634548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Demine S, Schulte ML, Territo PR, Eizirik DL. Beta Cell Imaging-From Pre-Clinical Validation to First in Man Testing. Int J Mol Sci 2020;21:E7274. [PMID: 33019671 DOI: 10.3390/ijms21197274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Haliyur R, Walker JT, Sanyoura M, Reihsmann CV, Shrestha S, Aramandla R, Poffenberger G, Ramirez AH, Redick SD, Babon JAB, Prasad N, Hegele RA, Kent SC, Harlan DM, Bottino R, Philipson LH, Brissova M, Powers AC. Integrated Analysis of the Pancreas and Islets Reveals Unexpected Findings in Human Male With Type 1 Diabetes. J Endocr Soc 2021;5:bvab162. [PMID: 34870058 DOI: 10.1210/jendso/bvab162] [Reference Citation Analysis]
14 Neiman D, Gillis D, Piyanzin S, Cohen D, Fridlich O, Moss J, Zick A, Oron T, Sundberg F, Forsander G, Skog O, Korsgren O, Levy-Khademi F, Arbel D, Hashavia S, Shapiro AMJ, Speake C, Greenbaum C, Hosford J, Posgai A, Atkinson MA, Glaser B, Schatz DA, Shemer R, Dor Y. Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic β cells. JCI Insight 2020;5:136579. [PMID: 32573495 DOI: 10.1172/jci.insight.136579] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
15 Roep BO, Thomaidou S, van Tienhoven R, Zaldumbide A. Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?). Nat Rev Endocrinol 2021;17:150-61. [PMID: 33293704 DOI: 10.1038/s41574-020-00443-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
16 Cheung P, Eriksson O. The Current State of Beta-Cell-Mass PET Imaging for Diabetes Research and Therapies. Biomedicines 2021;9:1824. [PMID: 34944640 DOI: 10.3390/biomedicines9121824] [Reference Citation Analysis]
17 Sims EK, DiMeglio LA. Cause or effect? A review of clinical data demonstrating beta cell dysfunction prior to the clinical onset of type 1 diabetes. Mol Metab 2019;27S:S129-38. [PMID: 31500824 DOI: 10.1016/j.molmet.2019.06.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
18 Marroqui L, Perez-Serna AA, Babiloni-Chust I, Dos Santos RS. Type I interferons as key players in pancreatic β-cell dysfunction in type 1 diabetes. Int Rev Cell Mol Biol 2021;359:1-80. [PMID: 33832648 DOI: 10.1016/bs.ircmb.2021.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kharbikar BN, Chendke GS, Desai TA. Modulating the foreign body response of implants for diabetes treatment. Adv Drug Deliv Rev 2021;174:87-113. [PMID: 33484736 DOI: 10.1016/j.addr.2021.01.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
20 Billert M, Rak A, Nowak KW, Skrzypski M. Phoenixin: More than Reproductive Peptide. Int J Mol Sci 2020;21:E8378. [PMID: 33171667 DOI: 10.3390/ijms21218378] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Sims EK, Syed F, Nyalwidhe J, Bahnson HT, Haataja L, Speake C, Morris MA, Balamurugan AN, Mirmira RG, Nadler J, Mastracci TL, Arvan P, Greenbaum CJ, Evans-Molina C. Abnormalities in proinsulin processing in islets from individuals with longstanding T1D. Transl Res 2019;213:90-9. [PMID: 31442418 DOI: 10.1016/j.trsl.2019.08.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
22 Alam M, Arunagiri A, Haataja L, Torres M, Larkin D, Kappler J, Jin N, Arvan P. Predisposition to Proinsulin Misfolding as a Genetic Risk to Diet-Induced Diabetes. Diabetes 2021;70:2580-94. [PMID: 34462258 DOI: 10.2337/db21-0422] [Reference Citation Analysis]
23 Erdem N, Montero E, Roep BO. Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2021;28:397-403. [PMID: 34183540 DOI: 10.1097/MED.0000000000000646] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Kahn SE, Chen YC, Esser N, Taylor AJ, van Raalte DH, Zraika S, Verchere CB. The β Cell in Diabetes: Integrating Biomarkers with Functional Measures. Endocr Rev 2021:bnab021. [PMID: 34180979 DOI: 10.1210/endrev/bnab021] [Reference Citation Analysis]
25 Curran M, Drayson MT, Andrews RC, Zoppi C, Barlow JP, Solomon TPJ, Narendran P. The benefits of physical exercise for the health of the pancreatic β-cell: a review of the evidence. Exp Physiol 2020;105:579-89. [PMID: 32012372 DOI: 10.1113/EP088220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
26 Sims EK, Mirmira RG, Evans-Molina C. The role of beta-cell dysfunction in early type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2020;27:215-24. [PMID: 32618633 DOI: 10.1097/MED.0000000000000548] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
27 Yeo L, Pujol-Autonell I, Baptista R, Eichmann M, Kronenberg-Versteeg D, Heck S, Dolton G, Sewell AK, Härkönen T, Mikk ML, Toppari J, Veijola R, Knip M, Ilonen J, Peakman M. Circulating β cell-specific CD8+ T cells restricted by high-risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetes. Clin Exp Immunol 2020;199:263-77. [PMID: 31660582 DOI: 10.1111/cei.13391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
28 Eizirik DL, Pasquali L, Cnop M. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol 2020;16:349-62. [PMID: 32398822 DOI: 10.1038/s41574-020-0355-7] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 39.0] [Reference Citation Analysis]
29 Bini J, Sanchez-Rangel E, Gallezot JD, Naganawa M, Nabulsi N, Lim K, Najafzadeh S, Shirali A, Ropchan J, Matuskey D, Huang Y, Herold KC, Harris PE, Sherwin RS, Carson RE, Cline GW. PET Imaging of Pancreatic Dopamine D2 and D3 Receptor Density with 11C-(+)-PHNO in Type 1 Diabetes. J Nucl Med 2020;61:570-6. [PMID: 31601695 DOI: 10.2967/jnumed.119.234013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
30 Murakami T, Fujimoto H, Inagaki N. Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond. Front Endocrinol (Lausanne) 2021;12:714348. [PMID: 34248856 DOI: 10.3389/fendo.2021.714348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Villalba A, Rodriguez-Fernandez S, Perna-Barrull D, Ampudia RM, Gomez-Muñoz L, Pujol-Autonell I, Aguilera E, Risueño RM, Cano-Sarabia M, Maspoch D, Vázquez F, Vives-Pi M. Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes. Sci Rep 2020;10:18927. [PMID: 33144616 DOI: 10.1038/s41598-020-76041-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Da Silva Xavier G, Rutter GA. Metabolic and Functional Heterogeneity in Pancreatic β Cells. J Mol Biol 2020;432:1395-406. [PMID: 31419404 DOI: 10.1016/j.jmb.2019.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
33 Gotthardt M, Joosten L, Jansen TJP, Brom M, Boss M, Willekens SMA. From Mice to Humans: The Exocrine Pancreas Does Not Matter in Human GLP-1 Receptor Imaging. J Nucl Med 2021;62:745. [PMID: 33608428 DOI: 10.2967/jnumed.120.259184] [Reference Citation Analysis]
34 Joosten L, Brom M, Peeters H, Bos D, Himpe E, Bouwens L, Boerman O, Gotthardt M. Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis. Mol Pharmaceutics 2019;16:4024-30. [DOI: 10.1021/acs.molpharmaceut.9b00728] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
35 Pinheiro MM, Pinheiro FMM, Diniz SN, Fabbri A, Infante M. Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes. Int Immunopharmacol 2021;95:107518. [PMID: 33756226 DOI: 10.1016/j.intimp.2021.107518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Ghawil M, Abdulrahman F, Hadeed I, Doggah M, Zarroug S, Habeb A. Further evidence supporting the role of DUT gene in diabetes with bone marrow failure syndrome. Am J Med Genet A 2022. [PMID: 35611808 DOI: 10.1002/ajmg.a.62771] [Reference Citation Analysis]
37 Budd MA, Monajemi M, Colpitts SJ, Crome SQ, Verchere CB, Levings MK. Interactions between islets and regulatory immune cells in health and type 1 diabetes. Diabetologia 2021;64:2378-88. [PMID: 34550422 DOI: 10.1007/s00125-021-05565-6] [Reference Citation Analysis]
38 Bolla AM, Gandolfi A, Borgonovo E, Laurenzi A, Caretto A, Molinari C, Catalano RS, Bianconi E, Monti P, Sordi V, Pellegrini S, Lampasona V, Costa S, Scavini M, Bosi E, Piemonti L. Rapamycin Plus Vildagliptin to Recover β-Cell Function in Long-Standing Type 1 Diabetes: A Double-Blind, Randomized Trial. The Journal of Clinical Endocrinology & Metabolism 2021;106:e507-19. [DOI: 10.1210/clinem/dgaa791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Blanter M, Sork H, Tuomela S, Flodström-Tullberg M. Genetic and Environmental Interaction in Type 1 Diabetes: a Relationship Between Genetic Risk Alleles and Molecular Traits of Enterovirus Infection? Curr Diab Rep 2019;19:82. [PMID: 31401790 DOI: 10.1007/s11892-019-1192-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
40 Yu MG, Keenan HA, Shah HS, Frodsham SG, Pober D, He Z, Wolfson EA, D'Eon S, Tinsley LJ, Bonner-Weir S, Pezzolesi MG, King GL. Residual β cell function and monogenic variants in long-duration type 1 diabetes patients. J Clin Invest 2019;129:3252-63. [PMID: 31264968 DOI: 10.1172/JCI127397] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
41 Ullsten S, Espes D, Quach M, Fex M, Sandberg M, Carlsson PO. Highly blood perfused, highly metabolically active pancreatic islets may be more susceptible for immune attack. Physiol Rep 2020;8:e14444. [PMID: 32618430 DOI: 10.14814/phy2.14444] [Reference Citation Analysis]
42 Marfil‐garza BA, Polishevska K, Pepper AR, Korbutt GS. Current State and Evidence of Cellular Encapsulation Strategies in Type 1 Diabetes. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 839-78. [DOI: 10.1002/cphy.c190033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
43 Chen YS, Weng SJ, Chang SH, Li RY, Shane GT, Hsu JP, Yeh SW, Chang AC, Lee MJ. Evaluating the antidiabetic effects of R-verapamil in type 1 and type 2 diabetes mellitus mouse models. PLoS One 2021;16:e0255405. [PMID: 34358247 DOI: 10.1371/journal.pone.0255405] [Reference Citation Analysis]
44 Sævik ÅB, Åkerman AK, Methlie P, Quinkler M, Jørgensen AP, Höybye C, Debowska AJ, Nedrebø BG, Dahle AL, Carlsen S, Tomkowicz A, Sollid ST, Nermoen I, Grønning K, Dahlqvist P, Grimnes G, Skov J, Finnes T, Valland SF, Wahlberg J, Holte SE, Simunkova K, Kämpe O, Husebye ES, Bensing S, Øksnes M. Residual Corticosteroid Production in Autoimmune Addison Disease. J Clin Endocrinol Metab 2020;105:dgaa256. [PMID: 32392298 DOI: 10.1210/clinem/dgaa256] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
45 Nimkulrat SD, Bernstein MN, Ni Z, Brown J, Kendziorski C, Blum B. The Anna Karenina Model of β-Cell Maturation in Development and Their Dedifferentiation in Type 1 and Type 2 Diabetes. Diabetes 2021;70:2058-66. [PMID: 34417264 DOI: 10.2337/db21-0211] [Reference Citation Analysis]
46 Eizirik DL, Szymczak F, Alvelos MI, Martin F. From Pancreatic β-Cell Gene Networks to Novel Therapies for Type 1 Diabetes. Diabetes 2021;70:1915-25. [PMID: 34417266 DOI: 10.2337/dbi20-0046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Mukherjee N, Lin L, Contreras CJ, Templin AT. β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances. Metabolites 2021;11:796. [PMID: 34822454 DOI: 10.3390/metabo11110796] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
48 Bauer W, Gyenesei A, Krętowski A. The Multifactorial Progression from the Islet Autoimmunity to Type 1 Diabetes in Children. Int J Mol Sci 2021;22:7493. [PMID: 34299114 DOI: 10.3390/ijms22147493] [Reference Citation Analysis]
49 Cefalu WT, Andersen DK, Arreaza-Rubín G, Pin CL, Sato S, Verchere CB, Woo M, Rosenblum ND; symposium planning committee, moderators, and speakers. Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases. Can J Diabetes 2021:S1499-2671(21)00396-8. [PMID: 34794897 DOI: 10.1016/j.jcjd.2021.09.126] [Reference Citation Analysis]
50 Miceli V, Fornasier M, Bulati M, Amico G, Conaldi PG, Casu A, Murgia S. In Vitro Evaluation of Nanoerythrosome Cytotoxicity and Uptake in Pancreatic Endothelial Cells: Implications for β-Cell Imaging Applications. Langmuir. [DOI: 10.1021/acs.langmuir.1c03153] [Reference Citation Analysis]
51 Moin ASM, Butler AE. Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes. Curr Diab Rep 2019;19:83. [PMID: 31401713 DOI: 10.1007/s11892-019-1194-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
52 Krentz NAJ, Shea LD, Huising MO, Shaw JAM. Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering. Lancet Diabetes Endocrinol 2021;9:708-24. [PMID: 34480875 DOI: 10.1016/S2213-8587(21)00170-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]